AxCell Labs

AxCell Labs creates biocompatible soft tissue implants derived from bacterial cellulose using a proprietary process designed to enhance tissue regeneration through cell colonization. The depyrogenation process developed by AxCell Labs exceeds FDA standards by 5X and offers superior efficiency, reduces production time, and enhances safety and applicability of bacterial cellulose in medical applications such as reconstructive surgeries.